Uri Lopatin

Uri Lopatin

Directeur Général chez
Ukko Inc.
54 ans
Health Technology
Consumer Services
Finance

Profil

Uri A. Lopatin was the founder of Assembly Pharmaceuticals, Inc., founded in 2012, serving as Chief Medical Officer & VP-Research & Development.
Dr. Lopatin was the founder of Assembly Biosciences, Inc., founded in 2005, serving as Scientific & Strategic Advisor from 2019 to 2022.
Dr. Lopatin was the founder of Pardes Biosciences, Inc., founded in 2020, serving as Director from 2022 to 2023.
Dr. Lopatin is currently Chief Executive Officer at Ukko, Inc. since 2024 and Operating Partner at Khosla Ventures LLC since 2023.
Former positions include Director-Clinical & Translational Research at Gilead Sciences, Inc. from 2010 to 2012 and Associate Director at Schering-Plough Research Institute from 2007 to 2008.
Education includes graduate and undergraduate degrees from Cornell University in 1994, a graduate degree from New York University in 2003, a graduate degree from UW Medicine in 2001, a doctorate from New Jersey Medical School in 2000, and a graduate degree from National Institutes of Health in 2006.

Postes actifs de Uri Lopatin

SociétésPosteDébut
Private Equity Investor 01/08/2023
Directeur Général 01/11/2024

Anciens postes connus de Uri Lopatin

SociétésPosteFin
PARDES BIOSCIENCES, INC. Fondateur 30/08/2023
ASSEMBLY BIOSCIENCES, INC. Fondateur 01/03/2022
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/09/2012
Private Equity Investor 01/04/2008
Fondateur -
Voir l'expérience en détail de Uri Lopatin

Formation de Uri Lopatin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

82

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

  1. Bourse
  2. Insiders
  3. Uri Lopatin
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇